Cargando…

Unconventional but effective: breaking through IBS-D clinical practice guidelines – correspondence

Irritable Bowel Syndrome (IBS) is a chronic, one of the commonest and persistent gastrointestinal (GI) disorder. Previously, the management plan for IBS-D included enhancing awareness; first line treatment included an increased dietary fiber intake, opioids for diarrhea and antispasmodics for pain m...

Descripción completa

Detalles Bibliográficos
Autores principales: Shaikh, Omer Ahmed, Shaikh, Gulrukh, Aftab, Rameel Muhammad, Baktashi, Haisum, Ullah, Irfan, Asghar, Muhammad Sohaib
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129270/
https://www.ncbi.nlm.nih.gov/pubmed/37113818
http://dx.doi.org/10.1097/MS9.0000000000000338
_version_ 1785030697149267968
author Shaikh, Omer Ahmed
Shaikh, Gulrukh
Aftab, Rameel Muhammad
Baktashi, Haisum
Ullah, Irfan
Asghar, Muhammad Sohaib
author_facet Shaikh, Omer Ahmed
Shaikh, Gulrukh
Aftab, Rameel Muhammad
Baktashi, Haisum
Ullah, Irfan
Asghar, Muhammad Sohaib
author_sort Shaikh, Omer Ahmed
collection PubMed
description Irritable Bowel Syndrome (IBS) is a chronic, one of the commonest and persistent gastrointestinal (GI) disorder. Previously, the management plan for IBS-D included enhancing awareness; first line treatment included an increased dietary fiber intake, opioids for diarrhea and antispasmodics for pain management. A recent treatment guideline by the American Gastroenterology Association (AGA) suggests a modified approach to treating patients with IBS-D. Eight drug recommendations were made, and a set of instructions on when to employ which medication was devised. With the incorporation of these structured guidelines, a more tailored and focused approach to IBS management may become plausible.
format Online
Article
Text
id pubmed-10129270
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-101292702023-04-26 Unconventional but effective: breaking through IBS-D clinical practice guidelines – correspondence Shaikh, Omer Ahmed Shaikh, Gulrukh Aftab, Rameel Muhammad Baktashi, Haisum Ullah, Irfan Asghar, Muhammad Sohaib Ann Med Surg (Lond) Correspondence, Commentaries and Perspectives Irritable Bowel Syndrome (IBS) is a chronic, one of the commonest and persistent gastrointestinal (GI) disorder. Previously, the management plan for IBS-D included enhancing awareness; first line treatment included an increased dietary fiber intake, opioids for diarrhea and antispasmodics for pain management. A recent treatment guideline by the American Gastroenterology Association (AGA) suggests a modified approach to treating patients with IBS-D. Eight drug recommendations were made, and a set of instructions on when to employ which medication was devised. With the incorporation of these structured guidelines, a more tailored and focused approach to IBS management may become plausible. Lippincott Williams & Wilkins 2023-03-27 /pmc/articles/PMC10129270/ /pubmed/37113818 http://dx.doi.org/10.1097/MS9.0000000000000338 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (https://creativecommons.org/licenses/by/4.0/) (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/)
spellingShingle Correspondence, Commentaries and Perspectives
Shaikh, Omer Ahmed
Shaikh, Gulrukh
Aftab, Rameel Muhammad
Baktashi, Haisum
Ullah, Irfan
Asghar, Muhammad Sohaib
Unconventional but effective: breaking through IBS-D clinical practice guidelines – correspondence
title Unconventional but effective: breaking through IBS-D clinical practice guidelines – correspondence
title_full Unconventional but effective: breaking through IBS-D clinical practice guidelines – correspondence
title_fullStr Unconventional but effective: breaking through IBS-D clinical practice guidelines – correspondence
title_full_unstemmed Unconventional but effective: breaking through IBS-D clinical practice guidelines – correspondence
title_short Unconventional but effective: breaking through IBS-D clinical practice guidelines – correspondence
title_sort unconventional but effective: breaking through ibs-d clinical practice guidelines – correspondence
topic Correspondence, Commentaries and Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129270/
https://www.ncbi.nlm.nih.gov/pubmed/37113818
http://dx.doi.org/10.1097/MS9.0000000000000338
work_keys_str_mv AT shaikhomerahmed unconventionalbuteffectivebreakingthroughibsdclinicalpracticeguidelinescorrespondence
AT shaikhgulrukh unconventionalbuteffectivebreakingthroughibsdclinicalpracticeguidelinescorrespondence
AT aftabrameelmuhammad unconventionalbuteffectivebreakingthroughibsdclinicalpracticeguidelinescorrespondence
AT baktashihaisum unconventionalbuteffectivebreakingthroughibsdclinicalpracticeguidelinescorrespondence
AT ullahirfan unconventionalbuteffectivebreakingthroughibsdclinicalpracticeguidelinescorrespondence
AT asgharmuhammadsohaib unconventionalbuteffectivebreakingthroughibsdclinicalpracticeguidelinescorrespondence